Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Moreover, low miR-143 and high GSK3-β, RAF1, paxillin, and p21CIP1 expression levels in a large cohort of patients with breast cancer were associated with worst outcome.
|
30755102 |
2019 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
We examined senescence induced by ionizing irradiation or ectopic overexpression of the stoichiometric cyclin-dependent kinase (CDK) inhibitor p21<sup>CIP/WAF1/SDI1</sup> in the human breast cancer cell line MCF7.
|
30987592 |
2019 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the pharmacological approaches to target p21<sup>Waf1/Cip1</sup> expression for therapy of breast cancer are clarified.
|
30255294 |
2019 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Berberine showed cytotoxicity to breast cancer cells, with an increase in the levels of p21/cip1 and p27/kip1, cyclin-dependent kinase inhibitors (CDKI), but mechanisms involved in up-regulating these molecules are largely unknown.
|
30911957 |
2019 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
|
31169265 |
2019 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
RUSC1-AS1 is highly expressed in BCa, which promotes the progression of BCa through mediating CDKN1A and KLF2.
|
31378902 |
2019 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
We found that the novel tetrapeptide modulator causes moderate cytotoxicity to the human breast cancer cell (MCF-7 cell), induces the apoptotic death of MCF-7 cell, and activates the tumor suppressor proteins p53 and cyclin-dependent kinase inhibitor 1 (p21).
|
28558224 |
2018 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Taken together, our results suggest that TA modulates EGF-R/Jak2/STAT1/3 and P38/STAT1/p21<sup>Waf1/Cip1</sup> pathways and induce G1-arrest and intrinsic apoptosis in breast carcinomas.
|
27862996 |
2017 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Furthermore, depletion of STAT1 in CAFs significantly reduced periductal reactive fibrosis and delayed early breast cancer progression <i>in vivo</i> Finally, cotreatment with fludarabine, a FDA-approved STAT1 activation inhibitor and DNA synthesis inhibitor, in combination with doxorubicin, showed enhanced therapeutic efficacy in treating mouse mammary gland tumors.
|
28108623 |
2017 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, friedelin effectively inhibit breast cancer MCF-7 cell growth, it was associated with early expression of Cdkn1a, pRb2 and activation of p53 and caspases.
|
28619518 |
2017 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
|
28106536 |
2017 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
In addition, CDKN1A mRNA and p21 protein expression were significantly increased in all breast cancer cell lines upon β-catenin silencing.
|
25663530 |
2016 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the antiproliferative effect of silencing FLOT2 on breast cancer cells was associated with upregulation of cyclin-dependent kinase (CDK) inhibitors p21Cip1 and p27Kip1.
|
25738752 |
2015 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Analysis of breast cancer samples reveals that a high LRH-1 level is inversely correlated with CDKN1A expression in breast cancer patients and is associated with poor prognosis.
|
25435372 |
2015 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Thus, our findings revealed resveratrol and curcumin synergistically caused apoptosis in cigarette smoke induced breast cancer cells through p2(Waf/Cip1) mediated inhibition of Hedgehog-Gli cascade.
|
26212257 |
2015 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
This agent is reported to increase the levels of p21WAF1/CIP1 in human breast cancer cell lines.
|
24568526 |
2014 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
We investigated the effect of the transfected p21 (Waf1) -p27 (Kip1) gene on centrosome duplication, cell proliferation, and apoptosis of MCF-7, a breast cancer cell line.
|
23338153 |
2014 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
We show that invasiveness of breast cancer cells is associated with growth arrest due to p21CIP1 upregulation.
|
22751124 |
2013 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
In addition, via qRT-PCR analysis of MDA-MB-231 cells, we observed that TNFα mediated the upregulation of gene transcripts associated with inflammation and senescence [IL-1-β, IL-6, IL-8, MCP-1, COX-2, p21(WAF1/CIP1)] and downregulated known tumor-promoting genes (collagen VI and MMP2).
|
23292149 |
2013 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
|
23184467 |
2013 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
However, a significant 2.21-fold increase in the chance of developing breast cancer was observed in the candidates carrying at least one allele Arg mutant in p21/CIP1 genotype (i.e., Ser/Arg + Arg/Arg) with age >50 (OR = 2.21; 95 % CI 1.03-4.79).
|
24005533 |
2013 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.
|
24027428 |
2013 |
Breast Carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGFβ)-mediated breast cancer cell migration and invasion.
|
22995475 |
2012 |
Breast Carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Strikingly, we found that silencing FLOT1 inhibited proliferation and tumorigenicity of breast cancer cells both in vitro and in vivo, which was further shown to be mechanistically associated with suppression of Akt activity, enhanced transcriptional activity of FOXO3a, upregulation of cyclin-dependent kinase inhibitor p21(Cip1) and p27(Kip1), and downregulation of the CDK regulator cyclin D1.
|
21447726 |
2011 |